Mesalamine Capsule, Extended Release
Product Images NDC 0781-2793

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Mesalamine (NDC 0781-2793). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sandoz Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (250 mg Capsule Bottle Label)

Label for Mesalamine Extended-Release Capsules USP 250 mg by Sandoz Inc. The label indicates a pharmacy bulk package containing 240 extended-release capsules. It includes storage instructions, a warning to keep out of reach of children, and mentions the capsules are manufactured by Fourrts (India) Laboratories for Sandoz Inc. in the USA.*

FDA Label Image

Principal Display Panel (500 mg Capsule Bottle Label)

Label for Mesalamine Extended-Release Capsules, USP 500 mg by Sandoz Inc. Contains 120 capsules. The label includes dosage strength, storage instructions (20° to 25°C), pharmacy bulk package warning, manufacturer details from Fourrts (India) Laboratories Pvt Ltd, and barcodes for product identification.*

FDA Label Image

Chemical Structure (Structure01)

Chemical structure of mesalamine showing a benzene ring with amino (NH2), hydroxyl (OH), and carboxyl (COOH) functional groups attached.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.